Mark R. Somerfield
0000-0001-5372-0085
Publication & Citation Trends
Most Cited Works
Publications
182 total
Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer: ASCO Guideline Update
Cited by 58
Semantic Scholar
Erratum: Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Systemic Cancer Therapy: ASCO Guideline Update.
Cited by 0
Semantic Scholar
Targeted Therapies, Sequencing Strategies, and Beyond in Metastatic Hormone Receptor-Positive Breast Cancer: ASCO Guideline Clinical Insights.
Cited by 9
Semantic Scholar
Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer-CDK4/6 Inhibitors: ASCO Rapid Guideline Update Clinical Insights.
Cited by 12
Semantic Scholar
Germline Testing in Patients With Breast Cancer: ASCO-Society of Surgical Oncology Guideline Q and A.
Cited by 8
Semantic Scholar
Endocrine and Targeted Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer-Capivasertib-Fulvestrant: ASCO Rapid Recommendation Update.
Cited by 31
Semantic Scholar
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology-College of American Pathologists Guideline Update. OA
Cited by 87
Semantic Scholar
Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline PDF
Cited by 957
OpenAlex
Research Topics
Breast Cancer Treatment Studies
(48)
Economic and Financial Impacts of Cancer
(19)
Health Systems, Economic Evaluations, Quality of Life
(18)
Cancer Treatment and Pharmacology
(16)
Colorectal Cancer Treatments and Studies
(15)
Frequent Co-Authors
Affiliations
Université Paris-Sud
Northwestern University
Ontario Institute for Cancer Research
University of North Carolina at Chapel Hill
Cedars-Sinai Medical Center